Back

Common pathophysiological mechanism of SAM and mitral regurgitation in HOCM

31 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Left ventricular outflow tract obstruction Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Associate Professor Zhenzhen Wang

Zhejiang Provincial People's Hospital, Hangzhou (China)

6 More presentations in this session

Presentation thumbnail
Multicenter study on the effect of Mavacamten on pulmonary artery systolic pressure derived from echo-doppler in obstructive hypertrophic cardiomyopathy
Doctor M. Gegenava (Tbilisi, GE)
Abstract Slides Video
Presentation thumbnail
Comparison of characteristics and outcomes of patients with obstructive vs. non-obstructive hypertrophic cardiomyopathy in a cohort from a referral center in colombia
Doctor J. Orozco Burbano (Medellin, CO)
Abstract Slides Video
Presentation thumbnail
Outcomes of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in Japan
Doctor T. Yamaguchi (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Genetic, echocardiographic and clinical determinants of mitral valve abnormalities in hypertrophic cardiomyopathy
Miss H. Panholzer (Graz, AT)
Abstract Slides Video
Presentation thumbnail
Impact of polypharmacy phenogroups on different heart failure phenotypes in patients with chronic heart failure (polypharmacy phenogroups and heart failure subgroups outcomes)
Doctor A. Aboughalia (Doha, QA)
Abstract Slides Video

Access the full session

Session thumbnail
Left ventricular outflow tract obstruction

The Event

Event poster

ESC Congress 2025

31 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Beyond the obstruction: mitral regurgitation in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
When mitral valve surgery makes the difference
thumbnail
Congress Presentation
Complex mitral cleft anatomy in a case of HCM: addressing multifactorial MR and the role of myosin inhibition

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources